Mini Review
Published on 18 Jul 2022
Nanobodies: COVID-19 and Future Perspectives
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.927164
- 10,960 views
- 15 citations
Type at least 3 characters
32 articles
articles
Clinical Trial
Published on 15 Jul 2022
Reszinate—A Phase 1/2 Randomized Clinical Trial of Zinc and Resveratrol Utilizing Home Patient-Obtained Nasal and Saliva Viral Sampling
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.910124
- 5,679 views
- 1 citation
Perspective
Published on 30 May 2022
Addressing Antibiotic Failure—Beyond Genetically Encoded Antimicrobial Resistance
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.892975
- 9,043 views
- 22 citations
Review
Published on 02 May 2022
Advances in Modelling COVID-19 in Animals
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.899587
- 10,885 views
- 1 citation
Review
Published on 25 Apr 2022
Developing Small-Molecule Inhibitors of Protein-Protein Interactions Involved in Viral Entry as Potential Antivirals for COVID-19
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.898035
- 7,484 views
- 15 citations
Mini Review
Published on 13 Apr 2022
COVID-19 Therapies: Protease Inhibitions and Novel Degrader Strategies
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.892057
- 4,101 views
- 6 citations
Review
Published on 30 Mar 2022
The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.837587
- 8,585 views
- 10 citations
Review
Published on 22 Mar 2022
Review of Clinical Trials of COVID-19 Vaccination Booster in SARS-CoV-2 Variants Era: To Take It or Not To Take It
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.858006
- 69,004 views
- 4 citations